Your browser is no longer supported. Please, upgrade your browser.
ABT Abbott Laboratories daily Stock Chart
Abbott Laboratories
IndexS&P 500 P/E48.31 EPS (ttm)0.90 Insider Own0.70% Shs Outstand1.71B Perf Week2.02%
Market Cap74.55B Forward P/E15.76 EPS next Y2.76 Insider Trans1.80% Shs Float1.71B Perf Month-2.26%
Income1.39B PEG4.31 EPS next Q0.60 Inst Own65.20% Short Float0.79% Perf Quarter8.25%
Sales22.30B P/S3.34 EPS this Y-58.60% Inst Trans0.32% Short Ratio1.74 Perf Half Y10.17%
Book/sh13.94 P/B3.12 EPS next Y11.78% ROA- Target Price48.15 Perf Year1.72%
Cash/sh- P/C- EPS next 5Y11.22% ROE- 52W Range35.85 - 45.56 Perf YTD14.76%
Dividend1.06 P/FCF- EPS past 5Y0.00% ROI6.70% 52W High-4.46% Beta1.43
Dividend %2.44% Quick Ratio- Sales past 5Y-0.50% Gross Margin55.50% 52W Low21.42% ATR0.60
Employees75000 Current Ratio- Sales Q/Q29.70% Oper. Margin11.00% RSI (14)44.88 Volatility1.75% 1.26%
OptionableYes Debt/Eq- EPS Q/Q489.50% Profit Margin6.70% Rel Volume0.96 Prev Close43.98
ShortableYes LT Debt/Eq- EarningsApr 19 BMO Payout107.10% Avg Volume7.81M Price43.53
Recom1.90 SMA20-0.69% SMA50-1.57% SMA2004.82% Volume7,519,613 Change-1.02%
Apr-20-17Reiterated Barclays Overweight $50 → $52
Mar-01-17Reiterated RBC Capital Mkts Outperform $46 → $50
Jan-26-17Reiterated RBC Capital Mkts Outperform $48 → $46
Jul-21-16Reiterated Barclays Overweight $48 → $50
Jun-21-16Upgrade Edward Jones Hold → Buy
Apr-11-16Reiterated RBC Capital Mkts Outperform $45 → $48
Jan-04-16Downgrade Morgan Stanley Overweight → Equal-Weight
Dec-07-15Upgrade Jefferies Hold → Buy
Nov-13-15Downgrade Goldman Buy → Neutral
Oct-09-15Reiterated RBC Capital Mkts Outperform $55 → $51
Oct-07-15Upgrade Barclays Equal Weight → Overweight $55 → $52
Jul-23-15Reiterated Stifel Buy $53 → $58
Jul-23-15Reiterated RBC Capital Mkts Outperform $51 → $55
Jul-23-15Reiterated Barclays Equal Weight $53 → $55
Apr-23-15Reiterated Stifel Buy $52 → $53
Mar-27-15Reiterated Barclays Equal Weight $48 → $52
Jan-30-15Reiterated Stifel Buy $47 → $49
Jan-30-15Reiterated Barclays Equal Weight $43 → $48
Sep-22-14Reiterated RBC Capital Mkts Outperform $44 → $48
Jul-17-14Reiterated Stifel Buy $42 → $47
Apr-21-17 02:33PM  AB's 4-star stock picks CNBC Videos
09:30AM  The Zacks Analyst Blog Highlights: IBM, Abbott, Dow Chemical, Delta Air Lines and Exelon Zacks
08:35AM  Edited Transcript of ABT earnings conference call or presentation 19-Apr-17 1:00pm GMT Thomson Reuters StreetEvents
Apr-20-17 02:58PM  Q1 Scorecard & Stock Research Reports for IBM, Abbott and others Zacks
02:43PM  LPC: US healthcare lending rouses from policy-induced sedation Reuters
11:51AM  [$$] GTCR Forms Medical-Device Platform The Wall Street Journal
11:02AM  Company News for April 20, 2017 Zacks
Apr-19-17 08:10PM  Abbott CEO Upbeat Despite Ongoing Merger Headaches
05:15PM  Merger Challenges, FDA Concerns Dampen Abbott Gains Despite Strong First Quarter
04:24PM  Abbott Delivers Street-Crushing Q1 Following St. Jude Buy Investor's Business Daily
12:22PM  Abbott sees Alere as challenging 'fixer-upper' after revised deal Reuters
10:48AM  Story Stocks from
10:44AM  Abbott (ABT) Tops Q1 Earnings on Strong EPD, Medical Device Zacks
10:03AM  Stocks to Watch: Morgan Stanley, IBM, Abbott Labs The Wall Street Journal
09:27AM  Abbott sales, profit propped up by St. Jude acquisition Reuters
09:20AM  Abbott Laboratories (ABT) Tops Q1 Earnings & Sales Estimates Zacks
09:13AM  Abbott's profit rises 33 percent after St. Jude Medical deal Associated Press
07:59AM  Abbott shares rise 2.5% after first-quarter earnings, profit beats MarketWatch
07:58AM  Abbott posts 29.7 pct rise in quarterly sales Reuters
07:51AM  Abbott Labs beats Street on top and bottom line CNBC Videos
07:45AM  Abbott Reports First-Quarter 2017 Results PR Newswire
07:06AM  Market Recon: The Banks Trade Will Become a Yield Curve Watch
Apr-18-17 01:55PM  5 Stocks with Great Earnings Charts Zacks
10:52AM  Company News for April 18, 2017 Zacks
Apr-17-17 11:59PM  [$$] Cyber Insurance Becomes a Must for More Manufacturers The Wall Street Journal
11:52PM  Asian stock markets mixed as North Korea tensions lessen Associated Press
04:37PM  Why Straight Path Communications, Alere, and MoneyGram International Jumped Today Motley Fool
04:17PM  Will Abbott, Alere Make It To Altar In New Merger Deal? Investor's Business Daily
02:05PM  Abbott Laboratories 1Q17 Earnings: What to Expect Market Realist
02:05PM  Abbott & Alere: Back Together Again
01:26PM  Carson Block Says Theres Temptation to Short Abbott Bloomberg Video
01:21PM  Alere Inc. Shares Surge After Renewed Commitment From Abbott Laboratories Motley Fool
12:35PM  Analyzing Abbott Laboratories 1Q17 Revenue Estimates Market Realist
11:16AM  Company News for April 17, 2017 Zacks
11:10AM  Abbott Laboratories : ABT-US: Dividend Analysis : April 14th, 2017 (record date) : By the numbers : April 17, 2017 Capital Cube
10:54AM  Abbott Laboratories: What Analysts Recommend ahead of Q1 Results Market Realist
09:49AM  Abbott Laboratories Agrees to Acquire Alere at Lower Price Zacks
09:38AM  Abbott and Alere: It's an M&A Miracle Bloomberg
07:07AM  [$$] Cyber Insurance Becomes a Must for More Manufacturers The Wall Street Journal
Apr-14-17 03:31PM  Earnings Season's Back: Stocks With Big Upside Benzinga
02:57PM  Abbott agrees to buy Alere at lower price from earlier offer Reuters
02:41PM  Abbott agrees to buy Alere at lower price from earlier offer Reuters
01:10PM  Alere agrees to discounted $5.3B merger with Abbott, ending legal battle American City Business Journals
11:30AM  Abbott finalizes discounted deal with Alere, ending legal battle American City Business Journals
07:01AM  Abbott to slash price it will pay for Alere by nearly 9% to about $5.3 billion MarketWatch
06:47AM  [$$] Abbott revises $5.3bn Alere deal to end legal spat Financial Times
06:00AM  Abbott and Alere Amend Terms of Merger Agreement PR Newswire
04:04AM  Abbott Laboratories to buy Alere for $4.4 bln - FT Reuters
03:58AM  Abbott Laboratories to buy Alere for $4.4 bln - FT Reuters
03:12AM  Abbott Said to Agree to Buy Alere at Lower Price, FT Reports Bloomberg
03:12AM  Abbott and Alere Agree to Play Nice With $5.3 Billion Deal Bloomberg
12:32AM  [$$] FDA Warns on Abbotts St. Jude Pacemakers and Defibrillators The Wall Street Journal
Apr-13-17 05:47PM  [$$] FDA Warns on Abbott's St. Jude Pacemakers and Defibrillators The Wall Street Journal
05:34PM  Abbott's St. Jude Medical Hit With FDA Warning Letter
12:32PM  Abbott stock drops 2% after FDA warning letter MarketWatch
10:00AM  Abbot Labs' FDA Warning Letter: How Worried Should You Be?
Apr-12-17 02:50PM  You Should Own J&J, Zimmer Biomet Ahead Of Earnings: RBC
09:59AM  Will Abbott Lab (ABT) Surprise Estimates in Q1 Earnings? Zacks
Apr-11-17 07:36AM  Analyzing the Performance of Abbott Laboratories in 1Q17 Market Realist
Apr-09-17 07:22AM  5 Pharmaceutical Stocks With the Most Reliable Dividends Motley Fool
Apr-07-17 09:10AM  Abbott Labs Stock Trades Ex-Dividend Tuesday Investopedia
Apr-06-17 09:41AM  4 Big Reasons Mylan N.V. Shares Fell 7% in March Motley Fool
08:30AM  Abbott Laboratories breached its 50 day moving average in a Bearish Manner : ABT-US : April 6, 2017 Capital Cube
Mar-31-17 09:44AM  Abbott's St Jude Buyout to Boost Business, Risks Remain Zacks
Mar-30-17 04:37PM  Moody's: Outlook for US medical products and devices industry remains stable Moody's
Mar-28-17 07:03AM  3 Things You Probably Didn't Know About AbbVie Inc. Motley Fool
Mar-24-17 05:25PM  Micron, SeaWorld and HCA jump while GameStop plunges
04:15PM  Mylan Topples After Big Med Player Divests 63% Of Its Shares Investor's Business Daily
03:28PM  Abbott Sells More Mylan Holdings
12:43PM  St. Jude Medical, Inc. -- Moody's withdraws St. Jude Medical's note ratings Moody's
11:41AM  Mylan Hit After Abbott Dumps Shares
11:18AM  [video]Can the Repeal of the Fiduciary Rule Harm Your Annuities Investments?
Mar-22-17 05:56PM  MedTech Long-Term Prospects Impress: Which Stocks to Buy? Zacks
02:47PM  ABBOTT LABORATORIES Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under an Off-Balan
02:47PM  Can Abbott Outperform Despite Alere?
09:00AM  Abbott Hosts Conference Call for First-Quarter Earnings PR Newswire
Mar-20-17 09:37AM  Abbott Labs Is Set to Go Substantially Higher
09:14AM  Abbott Laboratories' MitraClip Outcome Positive for DMR
Mar-19-17 02:00PM  Late-Breaking Data Shows the CardioMEMS HF System is Effective in Reducing Heart Failure Hospitalizations and Cost of Care PR Newswire
Mar-18-17 12:30PM  Late-Breaking Data on Abbott's MitraClip® System Show Continued Benefit for People with Mitral Regurgitation, Most Common Heart Valve Disease PR Newswire
Mar-16-17 11:51AM  Alere Delays Filing for 2nd Year in a Row
09:52AM  How to Get Diabetics Addicted to Data
08:05AM  Life-Saving Device Could Transform The Medical Market In 2017
Mar-15-17 11:34AM  Dealpolitik: Abbott Vs. Alere: A Case for Revising the MAE at The Wall Street Journal
08:00AM  GDS Investments Shares Bullish Theses on FMC, GM, Mosaic, More at Insider Monkey
07:36AM  Johnson & Johnsons Major Developments
Mar-14-17 06:07PM  Abbott Laboratories Downgraded by MBO
12:25PM  ABBOTT LABORATORIES Files SEC form 8-K, Change in Directors or Principal Officers
12:08PM  BMO On Abbott Labs: 'It's Likely Time For The Stock To Take A Pause'
08:42AM  Abbott Laboratories Stock Downgraded by BMO
Mar-13-17 08:01AM  The Next Big Biotech Breakthrough Could Just Be On The Horizon
Mar-10-17 03:05PM  Former Angels star faces federal insider trading charges at
Mar-08-17 05:15PM  AbbVie Is a Screaming Dividend Growth Buy... Here's Why
04:15PM  Abbott to Present at Barclays Capital 2017 Global Healthcare Conference PR Newswire
09:00AM  New Study Results May Lead to a New Standard of Care for In Vitro Fertilization Treatment PR Newswire
Mar-07-17 10:05AM  AAA Credit Rating Stocks in Focus: Johnson & Johnson
09:00AM  Abbott Announces Results of Early Tenders and Consents in Exchange Offers and Execution of Supplemental Indenture PR Newswire
07:43AM  Carson Block's short seller's strategy
Mar-03-17 02:21PM  Abbott Laboratories : ABT-US: Dividend Analysis : January 13th, 2017 (record date) : By the numbers : March 3, 2017
Mar-01-17 02:15PM  Alere delays annual filing for second year in a row at
Abbott Laboratories manufactures and sells health care products worldwide. The company's Established Pharmaceutical Products segment offers branded generic pharmaceuticals to treat pancreatic exocrine insufficiency; irritable bowel syndrome or biliary spasm; intrahepatic cholestasis or depressive symptoms; gynecological disorders; hormone replacement therapy; dyslipidemia; hypertension; hypothyroidism; Meniere's disease and vestibular vertigo; pain, fever, and inflammation; migraines; anti-infective clarithromycin; cardiovascular and metabolic products; and influenza vaccines, as well as to regulate physiological rhythm of the colon. Its Diagnostic Products segment provides immunoassay and clinical chemistry systems; assays used to screen and/or diagnosis cancer, cardiac, drugs of abuse, fertility, infectious diseases, and therapeutic drug monitoring; hematology systems and reagents; diagnostic systems and cartridges; instruments to automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detects and measures infectious agents; genomic-based tests; informatics and automation solutions; and a suite of informatics tools and professional services. The company's Nutritional Products segment provides pediatric and adult nutritional products. Its Vascular Products segment offers coronary, endovascular, vessel closure, and structural heart devices to treat vascular disease. The company also provides blood and flash glucose monitoring systems, including test strips, sensors, data management decision software, and accessories for people with diabetes; and medical devices for the eye, such as cataract and LASIK surgery, contact lens care, and dry eye products. It serves retailers, wholesalers, hospitals, health care facilities, laboratories, physicians' offices, and government agencies. The company was founded in 1888 and is headquartered in Abbott Park, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Contreras JaimeSenior Vice PresidentMar 31Sale44.6476734,2402,410Apr 04 05:02 PM
YOOR BRIAN BExecutive Vice President & CFOMar 01Sale45.391,72878,43463,425Mar 02 05:19 PM
NATH DEEPAK S.Senior Vice PresidentMar 01Sale45.391,60172,66951,430Mar 02 05:17 PM
Salvadori Daniel Gesua SiveSenior Vice PresidentMar 01Sale45.392,06693,77672,112Mar 02 05:16 PM
Watkin JaredSenior Vice PresidentMar 01Sale45.3997044,02848,511Mar 02 05:12 PM
Warmuth Michael JExecutive Vice PresidentMar 01Sale45.393,851174,79756,508Mar 02 05:04 PM
MANNING JOSEPH JSenior Vice PresidentFeb 28Sale44.9674433,45323,024Mar 02 05:18 PM
ALLEN HUBERT LExecutive Vice PresidentFeb 28Sale45.0185738,569100,879Mar 02 05:15 PM
BIRD ROGERSenior Vice PresidentFeb 28Sale45.021,60172,06956,913Mar 02 05:11 PM
Mason Heather LExecutive Vice PresidentFeb 28Sale45.011,91286,06859,677Mar 02 05:06 PM
Contreras JaimeSenior Vice PresidentFeb 28Sale45.0113,155592,15745,733Mar 02 05:05 PM
Funck Robert EVice President, ControllerFeb 23Option Exercise26.7025,500680,781117,579Feb 24 05:28 PM
Funck Robert EVice President, ControllerFeb 23Sale45.5025,5001,160,25092,079Feb 24 05:28 PM
BIRD ROGERSenior Vice PresidentFeb 22Option Exercise26.6212,903343,53975,767Feb 22 05:59 PM
BIRD ROGERSenior Vice PresidentFeb 22Sale45.0212,903580,93862,864Feb 22 05:59 PM
CAPEK JOHN MExecutive Vice PresidentFeb 21Option Exercise26.7093,4002,493,528382,197Feb 22 05:57 PM
MANNING JOSEPH JSenior Vice PresidentFeb 21Sale44.981466,56720,146Feb 22 06:18 PM
BIRD ROGERSenior Vice PresidentFeb 21Sale44.9431914,33562,864Feb 22 05:59 PM
CAPEK JOHN MExecutive Vice PresidentFeb 21Sale45.0093,4004,203,000288,797Feb 22 05:57 PM
Watkin JaredSenior Vice PresidentFeb 21Sale44.9855524,96551,977Feb 22 05:57 PM
NATH DEEPAK S.Senior Vice PresidentFeb 21Sale44.9831914,34957,333Feb 22 05:34 PM
ALLEN HUBERT LExecutive Vice PresidentFeb 13Option Exercise25.253,40085,83791,857Feb 15 05:04 PM
ALLEN HUBERT LExecutive Vice PresidentFeb 13Sale43.003,400146,20088,457Feb 15 05:04 PM
MANNING JOSEPH JSenior Vice PresidentFeb 03Option Exercise25.253007,57420,792Feb 07 05:02 PM
Mason Heather LExecutive Vice PresidentJan 31Option Exercise25.2535,700901,286100,189Feb 02 05:31 PM
Fussell Stephen RExecutive Vice PresidentJan 31Buy40.7712,200497,394167,167Feb 02 05:32 PM
Mason Heather LExecutive Vice PresidentJan 31Sale40.7735,7001,455,48964,489Feb 02 05:31 PM
Blaser Brian JExecutive Vice PresidentDec 20Buy38.4515,580599,120145,062Dec 21 02:19 PM
Ford Robert BExecutive Vice PresidentDec 14Buy39.0912,775499,34569,542Dec 16 05:07 PM
CAPEK JOHN MExecutive Vice PresidentNov 16Option Exercise24.3822,000536,386274,524Nov 18 05:02 PM
WHITE MILES DChairman and CEONov 10Buy40.6758,2632,369,4483,111,967Nov 14 10:04 AM
WHITE MILES DChairman and CEONov 10Buy40.5389,5783,630,2943,004,943Nov 14 10:03 AM
WHITE MILES DChairman and CEONov 10Buy40.6548,7611,982,0793,053,704Nov 14 10:03 AM
WHITE MILES DChairman and CEONov 10Buy40.5451,8922,103,4552,793,909Nov 14 10:02 AM
WHITE MILES DChairman and CEONov 10Buy40.45121,4564,912,7412,915,365Nov 14 10:02 AM
Blount Sally E.DirectorNov 01Buy39.245,100200,12420,143Nov 02 05:12 PM
Salvadori Daniel Gesua SiveSenior Vice PresidentSep 26Sale41.7181533,99458,976Sep 28 05:05 PM
FREYMAN THOMAS CExecutive Vice PresidentJul 29Option Exercise25.2556,0001,413,782438,682Jul 29 05:04 PM
Fussell Stephen RExecutive Vice PresidentJul 28Option Exercise25.2541,5001,047,713196,467Jul 29 05:03 PM
Fussell Stephen RExecutive Vice PresidentJul 28Sale45.0041,5001,867,640154,967Jul 29 05:03 PM
Warmuth Michael JExecutive Vice PresidentJul 26Option Exercise25.2526,800676,59581,811Jul 27 04:43 PM
Warmuth Michael JExecutive Vice PresidentJul 26Sale43.4926,8001,165,45755,011Jul 27 04:43 PM
WHITE MILES DChairman and CEOJul 25Option Exercise25.25550,00013,885,3552,010,517Jul 27 04:27 PM
Funck Robert EVice President, ControllerJul 25Option Exercise25.2526,800676,595111,819Jul 27 04:44 PM
WHITE MILES DChairman and CEOJul 25Buy43.3417,933777,1622,742,017Jul 27 04:31 PM
WHITE MILES DChairman and CEOJul 25Buy43.26176,8047,648,8232,724,084Jul 27 04:30 PM
WHITE MILES DChairman and CEOJul 25Buy43.19181,2637,828,6282,434,327Jul 27 04:29 PM
WHITE MILES DChairman and CEOJul 25Buy43.34112,9534,895,2172,547,280Jul 27 04:29 PM
WHITE MILES DChairman and CEOJul 25Buy43.18242,54710,472,9392,253,064Jul 27 04:27 PM
Funck Robert EVice President, ControllerJul 25Sale43.0826,8001,154,54485,019Jul 27 04:44 PM
ALLEN HUBERT LExecutive Vice PresidentJun 28Option Exercise20.753,40070,54591,857Jun 30 05:58 PM
ALLEN HUBERT LExecutive Vice PresidentJun 28Sale37.143,400126,27688,457Jun 30 05:58 PM
Watkin JaredSenior Vice PresidentJun 15Sale37.6355220,77046,562Jun 17 05:05 PM
YOOR BRIAN BSenior Vice President and CFOJun 01Sale39.4956522,31249,617Jun 03 05:10 PM
NATH DEEPAK S.Senior Vice PresidentApr 28Sale41.31532,18947,382Apr 29 05:01 PM